Submitted by Lisa Enever, Chloe’s Mother, Hertfordshire UK [Note from the SaneVax Team: We would like to thank Chloe and Lisa for granting us permission to publish their story. This account should help people remember that every major improvement in the human condition began with a single voice. Hopefully, it will be circulated widely to […]
Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective
Authors: Hirokuni Beppu, Masumi Minaguchi, Kiyoshi Uchide, Kunihiko Kumamoto, Masato Sekiguchi, Yukari Yaju Abstract: The human papillomavirus (HPV) vaccine has been linked to a number of serious adverse reactions. The range of symptoms is diverse and they develop in a multi-layered manner over an extended period of time. The argument for the safety and effectiveness of […]
Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination
Authors: Michelle M. Mello, JD, Ph.D., Sara Abiola, JD, Ph.D., and James Colgrove, PhD Abstract: Objectives. We sought to investigate roles that Merck & Co Inc played in state human papillomavirus (HPV) immunization policymaking, to elicit key stakeholders’ perceptions of the appropriateness of these activities, and to explore implications for relationships between health policymakers and industry. […]
NIH: Marketing HPV vaccines via censorship?
By Norma Erickson As an employee of the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), it is certainly within Dr. Mark Schiffman’s job description to write articles promoting human papillomavirus (HPV) vaccines. After all, his employer owns patents on HPV vaccine production technologies and receives licensing fees from the sales […]
HPV Vaccines: Public Acceptance or Psychological Manipulation?
By Norma Erickson What happens when a potential blockbuster vaccine (Gardasil, Cervarix, or Gardasil 9) is simply not accepted by the public on the same level as other recommended vaccines? Do the manufacturers and international health authorities re-examine the product to assess whether or not public concerns are valid? Not often, and when they do […]
- 1
- 2
- 3
- …
- 40
- Next Page »
